comparemela.com

Latest Breaking News On - Ancer of the thyroid - Page 1 : comparemela.com

GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk

A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.

Denmark
Sweden
Stockholm
Norway
Karolinska-institutet
Thyroid-cancer
Thyroid-carcinoma
Ancer-of-the-thyroid
Thyroid-disorder
Thyroid-disease
Thyroid-dysfunction

GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin

Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.

Lebanon
South-korea
New-york
United-states
Rachel-pessah
Dulaglutide-trulicity
Epic-research
University-of-north-carolina-at-chapel-hill
Novo-nordisk
While-the-epic-research
North-carolina
Chapel-hill

vimarsana © 2020. All Rights Reserved.